INVOLYS S.A. (CBSE:INV)

INVOLYS Income Statement

Financials in millions MAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	46.89	46.2	50.3	51.83	43.33
Revenue Growth (YoY)	1.49%	-8.16%	-2.95%	19.61%	-8.60%
Cost of Revenue	26.07	25.79	26.3	26.95	28.51
Gross Profit	20.82	20.41	24.01	24.89	14.83
Selling, General & Admin	5.14	6.03	6.89	5.88	6.92
Other Operating Expenses	14.01	12.61	12.55	16.05	5.04
Operating Expenses	19.15	18.65	19.44	21.92	11.96
Operating Income	1.66	1.76	4.57	2.96	2.86
Interest Expense	-1.1	-0.83	-0.97	-1.17	-0.86
Currency Exchange Gain (Loss)	-0.1	0.42	-0.66	-0.4	-0.23
Other Non Operating Income (Expenses)	-1.23	-0.38	0.99	-0.96	0.64
EBT Excluding Unusual Items	-0.77	0.98	3.93	0.43	2.41
Gain (Loss) on Sale of Assets	-	-	-	-	-0.66
Other Unusual Items	0.74	-0.2	-3	-0.24	-0.87
Pretax Income	-0.02	0.78	0.93	0.19	0.88
Income Tax Expense	0.1	0.09	1.03	0.18	0.47
Net Income	-0.12	0.69	-0.09	0.01	0.41
Net Income to Common	-0.12	0.69	-0.09	0.01	0.41
Net Income Growth	-	-	-	-98.68%	-89.14%
Shares Outstanding (Basic)	0	0	0	1	0
Shares Outstanding (Diluted)	0	0	0	1	0
Shares Change (YoY)	0.84%	0.63%	-29.98%	41.39%	0.39%
EPS (Basic)	-0.32	1.80	-0.24	0.01	1.07
EPS (Diluted)	-0.32	1.80	-0.24	0.01	1.07
EPS Growth	-	-	-	-99.06%	-89.18%
Free Cash Flow	-9.77	-0.24	-10.07	70.09	-
Free Cash Flow Per Share	-25.33	-0.63	-26.48	129.09	-
Gross Margin	44.40%	44.18%	47.73%	48.01%	34.22%
Operating Margin	3.55%	3.82%	9.08%	5.72%	6.61%
Profit Margin	-0.26%	1.49%	-0.18%	0.01%	0.95%
Free Cash Flow Margin	-20.85%	-0.52%	-20.02%	135.23%	-
EBITDA	2.26	2.31	5.12	-	3.24
EBITDA Margin	4.82%	5.00%	10.17%	-	7.47%
D&A For EBITDA	0.6	0.55	0.55	-	0.38
EBIT	1.66	1.76	4.57	2.96	2.86
EBIT Margin	3.55%	3.82%	9.08%	5.72%	6.61%
Effective Tax Rate	-	12.00%	109.76%	97.12%	53.19%
Revenue as Reported	46.98	46.52	49.7	51.63	47.66

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.